tiprankstipranks
pc:faeth

Faeth Therapeutics

Faeth Therapeutics is a clinical-stage biotechnology company developing multi-node therapies that block cancer growth signals while controlling tumor fuel supply, leveraging its AI-driven MetabOS™ platform to identify and exploit metabolic dependencies. In addition to advancing multiple solid-tumor studies, Faeth is advancing a translational program in Hereditary Tyrosinemia Type 1 (HT1), the first example of how its approach can extend beyond oncology into rare diseases.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$25M
Total Amount Raised$25M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$25M
Latest Funding Amount$25M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 20, 2025
Investment
$25.00M

Investors

Investor Name
Funding Round
Investment
Investment
Investment
Investment
Investment
Investment
Investment

Related News and Analysis